Granulocyte-macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) can promote Th17 differentiation and are second-line treatments for severe and invasive fungal infections in CMC (50). The gene discussed is CSF2; the disease is fungal infectious disease.